Ontology highlight
ABSTRACT: Background
Many recently approved medications to manage multiple myeloma (MM) are oral, require supportive medications to prevent adverse effects, and are taken under complex schedules. Medication adherence is a concern; however, little attention has been directed toward understanding adherence in MM or associated barriers and facilitators. Advanced sensored medication devices (SMDs) offer opportunities to intervene; however, acceptability among patients with MM, particularly African American patients, is untested.Objective
This study aimed to explore patients' (1) perceptions of their health before MM including experiences with chronic medications, (2) perceptions of adherence barriers and facilitators, and (3) attitudes toward using SMDs.Methods
An in-person, semi
SUBMITTER: Asfaw AA
PROVIDER: S-EPMC6256103 | biostudies-literature | 2018 Nov
REPOSITORIES: biostudies-literature